GlassScriptPhysician profile
James A Anderson
NPI 1821075904
$4,064.58
in general payments reported to CMS, 2019-2025
21 companies · $1,758 in 2025
The $1,758 reported for 2025 was more than what 81% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $86.42 · 2020: $32.76 · 2021: $116 · 2022: $221 · 2023: $1,133 · 2024: $717 · 2025: $1,758.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $2,089 · Food and Beverage: $1,520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $2,088.59 |
| Food and Beverage | $1,520.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $2,171.28 | 2022-2025 | Acell, Amnioexcel Plus, Amnioexcel |
| Smith+Nephew, INC. | $373.06 | 2019-2025 | Grafix Pl, Collagenase Santyl, Iodosorb Ointment 40g USA |
| Mimedx Group, INC. | $364.15 | 2025 | |
| Averitas Pharma INC. | $273.29 | 2023-2025 | Qutenza |
| Paratek Pharmaceuticals, INC. | $174.14 | 2024-2025 | Nuzyra |
| Zimmer Biomet Holdings, INC. | $121.49 | 2021-2023 | Subchondroplasty Knee Kit |
| Orthofix Medical, INC. | $118.86 | 2019-2023 | Physio-Stim |
| Abbvie INC. | $84.06 | 2021-2022 | |
| Bioventus LLC | $63.76 | 2019-2023 | Exogen Ultrasound Bone Healing System |
| Bone Support INC. | $46.37 | 2025 | Ceramentbone Void Filler, Cerament G |
| Horizon Therapeutics Plc | $36.08 | 2019-2021 | |
| Medtronic, INC. | $35.64 | 2024-2025 | Intellis Adaptivestim |
| Treace Medical Concepts, INC. | $35.08 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $30.56 | 2025 | |
| Ebi, LLC | $27.43 | 2025 | Biomet Orthopak Non-Invasive Bone Growth Stimulator System, Biomet Ebi Bone Healing System |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $23.06 | 2024 | Activ.A.C. |
| Baudax Bio INC. | $22.35 | 2021 | |
| Reprise Biomedical, INC. | $20.18 | 2024 | Miro3d |
| Biotissue Holdings INC. | $17.28 | 2021 | |
| Melinta Therapeutics, LLC | $14.34 | 2019 | |
| Triad Life Sciences INC. | $12.12 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.